Does UMECLIDINIUM Cause Benign prostatic hyperplasia? 97 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Benign prostatic hyperplasia have been filed in association with UMECLIDINIUM (Anoro Ellipta). This represents 1.5% of all adverse event reports for UMECLIDINIUM.
97
Reports of Benign prostatic hyperplasia with UMECLIDINIUM
1.5%
of all UMECLIDINIUM reports
14
Deaths
93
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From UMECLIDINIUM?
Of the 97 reports, 14 (14.4%) resulted in death, 93 (95.9%) required hospitalization, and 68 (70.1%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UMECLIDINIUM. However, 97 reports have been filed with the FAERS database.
What Other Side Effects Does UMECLIDINIUM Cause?
Dyspnoea (1,817)
Asthma (1,433)
Wheezing (1,111)
Therapeutic product effect incomplete (980)
Cough (913)
Drug ineffective (734)
Loss of personal independence in daily activities (711)
Obstructive airways disorder (654)
Chronic obstructive pulmonary disease (588)
Condition aggravated (580)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which UMECLIDINIUM Alternatives Have Lower Benign prostatic hyperplasia Risk?
UMECLIDINIUM vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UMECLIDINIUM vs UMIFENOVIR
UMECLIDINIUM vs UNSPECIFIED INGREDIENT
UMECLIDINIUM vs UPADACITINIB
UMECLIDINIUM vs URAPIDIL